Wednesday, October 20, 2021


WHO to take final decision to grant EUL to Covaxin next week

Hyderabad: The World Health Organization (WHO) tweeted on Tuesday that WHO and an independent group of experts will meet next week to carry out...

This silver medal is a big achievement: Humpy

Hyderabad: Even as the Indian team celebrated their first-ever podium finish with a silver medal in the Fide World chess championship in Sitges, Spain,...

Covid vaccine exclusively for adolescents likely

MoHFW may approve Covid vaccine this month for those aged between 12 years and 18 years

Decision on Bharat Biotech’s Covaxin in October: WHO

United Nations/Geneva: A decision on Bharat Biotech's submission seeking emergency use listing (EUL) for its Covaxin COVID-19 vaccine will be made in October, the...

Hyderabad: IICT team bags CSIR Technology Award 2021

Hyderabad: The Council of Scientific & Industrial Research (CSIR) - Indian Institute of Chemical Technology (IICT), Hyderabad, team led by director Dr. S Chandrasekhar...

Vaccine must not be entry barrier for nations: Bharat Biotech

New Delhi: The Co-founder and Joint Managing Director of Hyderabad-based Bharat Biotech, Suchitra Ella has said that vaccines should not be a barrier to...

Bharat Biotech completes phase 2 trials for kids

Hyderabad: Bharat Biotech completed the Phase 2/3 trials of Covid-19 vaccine, Covaxin for use in children under 18 years of age and is expected...

First commercial batch of Covaxin manufactured in Ankleshwar launched

Union minister of Health and Family Welfare Mansukh Mandaviya formally launched the Covaxin batches. Dr Krishna Ella, CMD, Bharat Biotech and Suchitra Ella, joint managing director, Bharat Biotech were also present at the launch.

Editorial: Boost to vaccination drive

Nod for Zydus Cadila'd Covid vaccine for children will help India ramp up its vaccination programme quickly

Indian Immunologicals ramping up Covaxin drug substance production

Output of Covaxin drug substance will be adequate for 3 to 4 million doses a month and from December it will increase to 10 million doses a month

Editorial: Mixing vaccines

It is argued that such a mixed regimen will help overcome the challenges of the shortfall of certain vaccines and remove hesitancy, especially in settings where multiple Covid-19 vaccines are being used

India’s drug regulator approves study on mixing of Covaxin and Covishield doses

An expert panel of the Central Drugs Standard Control Organisation (CDSCO) on July 29 had recommended granting permission for conducting the study.

Bharat Biotech’s Ankleshwar unit gets nod to make Covaxin

Bharat Biotech recently stated that products manufactured from Ankleshwar will be available for supplies during September.

Hyderabad: Special offer for Covaxin in Apollo Hospitals from Aug 12-21

Under the special freedom offer, Apollo Hospitals will offer the Covaxin vaccine at a no profit cost price of Rs.1,250.

Mixing Covishield, Covaxin provides better immunity: ICMR

The results of a study conducted by ICMR showed that the people in the mix and match group had superior immunogenicity profiles against Alpha, Beta and Delta variants of Covid-19

Latest News

- Advertisement -